Skip to main navigation Skip to search Skip to main content

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients

  • N. Gianotti
  • , F. Canducci
  • , L. Galli
  • , F. Cossarini
  • , S. Salpietro
  • , A. Poli
  • , S. Nozza
  • , V. Spagnuolo
  • , M. Clementi
  • , M. Sampaolo
  • , E. R. Ceresola
  • , S. Racca
  • , A. Lazzarin
  • , A. Castagna

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

In this single-centre, retrospective study, we analyzed data of 194 patients receiving antiretroviral therapy with <50 human immunodeficiency virus (HIV) RNA copies/mL in plasma and 318 HIV RNA/DNA paired samples. By kinetic polymerase chain reaction (kPCR) molecular system analysis, 104 (54%) subjects had undetectable HIV RNA and 90 (46%) had residual viraemia. Median (interquartile range) HIV DNA load was 780 (380-1930) copies/106 peripheral blood lymphocytes (PBL), and HIV DNA loads were independently associated with residual viraemia (p0.002). Virological rebound occurred in 29/194 (15%) patients over a median (interquartile range) follow-up of 17.5 (13.5-31.5) months. Residual viraemia (p 0.002), but not HIV DNA load, was independently associated with virological rebound.

Original languageEnglish
Pages (from-to)103.e7-103.e10
JournalClinical Microbiology and Infection
Volume21
Issue number1
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • HIV-1 DNA load
  • KPCR
  • Residual viraemia
  • Virological failure
  • Virological rebound

Fingerprint

Dive into the research topics of 'HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients'. Together they form a unique fingerprint.

Cite this